South Korea · Delayed Price · Currency is KRW MEDIPOST Statistics
Total Valuation
MEDIPOST has a market cap or net worth of KRW 399.06 billion. The enterprise value is 336.74 billion.
| Market Cap | 399.06B |
| Enterprise Value | 336.74B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDIPOST has 39.09 million shares outstanding. The number of shares has increased by 7.63% in one year.
| Current Share Class | 39.09M |
| Shares Outstanding | 39.09M |
| Shares Change (YoY) | +7.63% |
| Shares Change (QoQ) | -7.08% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 0.34% |
| Float | 20.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.40 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 1.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.08 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.64 |
| Interest Coverage | -12.41 |
Financial Efficiency
Return on equity (ROE) is -29.93% and return on invested capital (ROIC) is -36.42%.
| Return on Equity (ROE) | -29.93% |
| Return on Assets (ROA) | -9.11% |
| Return on Invested Capital (ROIC) | -36.42% |
| Return on Capital Employed (ROCE) | -21.66% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | 229.49M |
| Profits Per Employee | -247.10M |
| Employee Count | 322 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.42 |
Taxes
In the past 12 months, MEDIPOST has paid 747.56 million in taxes.
| Income Tax | 747.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.98% in the last 52 weeks. The beta is 0.57, so MEDIPOST's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -11.98% |
| 50-Day Moving Average | 19,468.00 |
| 200-Day Moving Average | 17,810.80 |
| Relative Strength Index (RSI) | 28.23 |
| Average Volume (20 Days) | 413,287 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MEDIPOST had revenue of KRW 73.90 billion and -79.57 billion in losses. Loss per share was -2,167.93.
| Revenue | 73.90B |
| Gross Profit | 46.90B |
| Operating Income | -71.10B |
| Pretax Income | -79.44B |
| Net Income | -79.57B |
| EBITDA | -65.52B |
| EBIT | -71.10B |
| Loss Per Share | -2,167.93 |
Balance Sheet
The company has 217.66 billion in cash and 154.58 billion in debt, with a net cash position of 63.08 billion or 1,613.84 per share.
| Cash & Cash Equivalents | 217.66B |
| Total Debt | 154.58B |
| Net Cash | 63.08B |
| Net Cash Per Share | 1,613.84 |
| Equity (Book Value) | 241.25B |
| Book Value Per Share | 6,154.88 |
| Working Capital | 20.04B |
Cash Flow
In the last 12 months, operating cash flow was -54.22 billion and capital expenditures -4.33 billion, giving a free cash flow of -58.55 billion.
| Operating Cash Flow | -54.22B |
| Capital Expenditures | -4.33B |
| Depreciation & Amortization | 5.58B |
| Net Borrowing | 204.23B |
| Free Cash Flow | -58.55B |
| FCF Per Share | -1,498.03 |
Margins
Gross margin is 63.46%, with operating and profit margins of -96.22% and -107.68%.
| Gross Margin | 63.46% |
| Operating Margin | -96.22% |
| Pretax Margin | -107.50% |
| Profit Margin | -107.68% |
| EBITDA Margin | -88.67% |
| EBIT Margin | -96.22% |
| FCF Margin | n/a |
Dividends & Yields
MEDIPOST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.63% |
| Shareholder Yield | -7.63% |
| Earnings Yield | -19.94% |
| FCF Yield | -14.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 29, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Mar 29, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MEDIPOST has an Altman Z-Score of 0.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 2 |